-
SMMT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Summit Therapeutics (SMMT)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 94.10 mm | 94.10 mm | 94.10 mm | 94.10 mm | 94.10 mm | 94.10 mm |
Cash burn (monthly) | (no burn) | (no burn) | 19.46 mm | 16.38 mm | 10.10 mm | 9.41 mm |
Cash used (since last report) | n/a | n/a | 88.38 mm | 74.41 mm | 45.87 mm | 42.73 mm |
Cash remaining | n/a | n/a | 5.72 mm | 19.69 mm | 48.23 mm | 51.37 mm |
Runway (months of cash) | n/a | n/a | 0.3 | 1.2 | 4.8 | 5.5 |
13F holders | Current |
---|---|
Total holders | 168 |
Opened positions | 65 |
Closed positions | 23 |
Increased positions | 50 |
Reduced positions | 33 |
13F shares | Current |
---|---|
Total value | 1.72 tn |
Total shares | 109.34 mm |
Total puts | 2.84 mm |
Total calls | 2.01 mm |
Total put/call ratio | 1.4 |
Largest owners | Shares | Value |
---|---|---|
Zanganeh Maky | 24.89 mm | $37.83 mm |
Baker Bros. Advisors | 24.42 mm | $534.90 bn |
Vanguard | 10.95 mm | $239.73 bn |
FMR | 8.30 mm | $181.84 bn |
BlackRock | 8.09 mm | $177.27 bn |
T. Rowe Price | 5.44 mm | $119.13 mm |
STT State Street | 3.47 mm | $75.96 bn |
Geode Capital Management | 3.10 mm | $67.90 bn |
Charles Schwab Investment Management | 1.43 mm | $31.38 bn |
Millennium Management | 1.22 mm | $26.77 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Jan 25 | Bhaskar Anand | Stock Option Common Stock | Grant | Acquire A | No | No | 17.85 | 75,000 | 1.34 mm | 75,000 |
2 Jan 25 | Robert F. Booth | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 6,855 | 62.93 k | 6,855 |
2 Jan 25 | Robert F. Booth | Stock Option Common Stock | Grant | Acquire A | No | No | 18.35 | 35,000 | 642.25 k | 35,000 |
2 Jan 25 | Alessandra Cesano | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 3,073 | 28.21 k | 3,073 |
2 Jan 25 | Alessandra Cesano | Stock Option Common Stock | Grant | Acquire A | No | No | 18.35 | 35,000 | 642.25 k | 35,000 |
2 Jan 25 | Ronaghi Mostafa | Stock Option Common Stock | Grant | Acquire A | No | No | 18.35 | 35,000 | 642.25 k | 35,000 |
2 Jan 25 | Clark Kenneth A | Stock Option Common Stock | Grant | Acquire A | No | No | 9.18 | 16,991 | 155.98 k | 16,991 |
2 Jan 25 | Clark Kenneth A | Stock Option Common Stock | Grant | Acquire A | No | No | 18.35 | 35,000 | 642.25 k | 35,000 |